23 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31586149 | In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site. | 2020 Feb | 1 |
2 | 31637414 | Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. | 2020 Apr 15 | 3 |
3 | 31714193 | MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization. | 2020 Jan | 1 |
4 | 31726354 | Development of a Microfluidic Culture Paradigm for Ex Vivo Maintenance of Human Glioblastoma Tissue: A New Glioblastoma Model? | 2020 Jan | 1 |
5 | 31833548 | The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas. | 2020 Aug 1 | 1 |
6 | 31908598 | Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas. | 2020 | 1 |
7 | 31929772 | Alterations of Mitochondria and Related Metabolic Pathways in Leukemia: A Narrative Review. | 2020 Jan-Apr | 1 |
8 | 31935911 | Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth. | 2020 Jan 6 | 1 |
9 | 31963507 | Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. | 2020 Jan 17 | 1 |
10 | 31969485 | The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. | 2020 Jan 22 | 2 |
11 | 32003035 | In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients. | 2020 Sep | 1 |
12 | 32025842 | Updates on DNA methylation modifiers in acute myeloid leukemia. | 2020 Apr | 1 |
13 | 32027343 | Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. | 2020 Apr 1 | 1 |
14 | 32055803 | Ivosidenib to treat adult patients with relapsed or refractory acute myeloid leukemia. | 2020 Jan | 1 |
15 | 31632056 | Detection Of Mutations In The Isocitrate Dehydrogenase Genes (IDH1/IDH2) Using castPCRTM In Patients With AML And Their Clinical Impact In Mexico City. | 2019 | 2 |
16 | 31660152 | Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. | 2019 | 2 |
17 | 31742037 | Maffucci Syndrome with Clival Enchondroma in Nasopharynx: A Case Report. | 2019 Oct | 1 |
18 | 31795195 | Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma. | 2019 Nov 28 | 1 |
19 | 31810230 | Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status. | 2019 Dec 2 | 1 |
20 | 31888244 | Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. | 2019 Dec 16 | 1 |
21 | 31907132 | [Value of Serum Tumor Marker Isocitrate Dehydrogenase 1 in the Diagnosis of Lung Cancer]. | 2019 Dec 30 | 1 |
22 | 31921378 | Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors. | 2019 Dec | 1 |
23 | 31921684 | Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses. | 2019 | 1 |